Phosphorylation of caspase-8 by RSKs via organ-constrained effects controls the sensitivity to TNF-induced death

Peng He,Tingting Ai,Muzhen Qiao,Zhang-Hua Yang,Jiahuai Han

DOI: https://doi.org/10.1038/s41420-024-02024-0

2024-05-25

Cell Death Discovery

Abstract:Caspase-8 (Casp8) serves as an initiator of apoptosis or a suppressor of necroptosis in context-dependent manner. Members of the p90 RSK family can phosphorylate caspase-8 at threonine-265 (T265), which can inactivate caspase-8 for bypassing caspase-8-mediated blockade of necroptosis and can also decrease caspase-8 level by promoting its degradation. Mutating T265 in caspase-8 to alanine (A) in mice blocked TNF-induced necroptotic cecum damage but resulted in unexpectedly massive injury in the small intestine. Here, we show RSK1, RSK2, and RSK3 redundantly function in caspase-8 phosphorylation, and the duodenum is the most severely affected part of the small intestine when T265 phosphorylation of caspase-8 was prevented. Eliminating caspase-8 phosphorylation resulted in a duodenum-specific increase in basal caspase-8 protein level, which shall be responsible for the increased sensitivity to TNF-induced damage. Apoptosis of intestinal epithelial cells (IECs) was predominant in the duodenum of TNF-treated Rsk1 − / − Rsk2 − / − Rsk3 − / − and Casp8 T265A/T265A mice, though necroptosis was also observed. The heightened duodenal injury amplified systemic inflammatory responses, as evidenced by the contribution of hematopoietic cells to the sensitization of TNF-induced animal death. Further analysis revealed that hematopoietic and non-hematopoietic cells contributed differentially to cytokine production in response to the increased cell death. Collectively, RSKs emerges as a previously overlooked regulator that, via tissue/organ-constrained inactivating caspase-8 and/or downregulating caspase-8 protein level, controls the sensitivity to TNF-induced organ injury and animal death.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the role of RSK family members in caspase - 8 phosphorylation in vivo in the cell death mechanism caused by tumor necrosis factor - α (TNF) and how it affects TNF - induced tissue damage and animal death. Specifically, the paper explores the following points:

1. **The role of RSK family members in caspase - 8 phosphorylation**:
- The study found that RSK1, RSK2 and RSK3 have redundant functions in the phosphorylation of caspase - 8 at the T265 site.
- This phosphorylation can lead to the inactivation or degradation of caspase - 8, thus affecting the choice of cell death pathways.

2. **The impact of the T265A mutation**:
- In mice, the T265A mutation of caspase - 8 prevents RSK - mediated phosphorylation, making the small intestine, especially the duodenum, more sensitive to TNF - induced damage.
- Conversely, this mutation inhibits cecal damage.

3. **Specific effects in different tissues**:
- In the cecum, phosphorylation of caspase - 8 promotes necroptosis, while in the duodenum, preventing phosphorylation increases the protein level of caspase - 8 and enhances apoptosis and necroptosis.
- This indicates that RSK - mediated caspase - 8 regulation has different effects in different tissues and is particularly important for maintaining the homeostasis of the small intestine.

4. **Regulation of the inflammatory response**:
- Preventing RSK - mediated caspase - 8 phosphorylation not only increases cell death but also amplifies the systemic inflammatory response.
- The study found that hematopoietic cells and non - hematopoietic cells play different roles in TNF - induced cell death and inflammatory response.

In summary, this paper aims to reveal the specific mechanism of RSK family members in TNF - induced cell death and tissue damage through phosphorylating caspase - 8, as well as the specific effects of this regulation in different tissues. These findings are helpful for understanding the complex role of the TNF signaling pathway in disease occurrence and may provide new targets for the treatment of related diseases.